Clearbridge Mid Cap Strategy Sold ICON Public Limited Company (ICLR) in Q1

2 hours ago 2

Soumya Eswaran

Mon, April 13, 2026 astatine 7:15 AM CDT 3 min read

ClearBridge Investments, a planetary equity manager, precocious published first-quarter 2026 commentary for its “Mid Cap Strategy”. A transcript of the missive tin be downloaded here. Mid-cap stocks showed beardown show successful Q1, with the Russell Midcap Index rising 1.3%, outperforming some large-cap and small-cap stocks. In contrast, large-cap equities dropped 4.2%, portion small-caps accrued by lone 0.9%; this dynamic suggested broadening successful marketplace leadership. Though capitalist concerns astir the US-Israel-Iran struggle influenced mid-cap stocks, their show was much focused connected institution fundamentals and assemblage trends. However, the ClearBridge Mid Cap Strategy underperformed its benchmark owed to challenges successful the IT, wellness care, and user discretionary sectors. The Strategy focuses connected the user discretionary sector, acquiring firms that tin execute successful a assortment of circumstances portion being adaptable arsenic the situation changes. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2026.

In its first-quarter 2026 capitalist letter, ClearBridge Mid Cap Strategy highlighted stocks similar ICON Public Limited Company (NASDAQ:ICLR). ICON Public Limited Company (NASDAQ:ICLR) is simply a objective probe enactment that provides outsourced improvement and commercialization services to the pharmaceutical, biotechnology, and aesculapian instrumentality industries. On April 10, 2026, ICON Public Limited Company (NASDAQ:ICLR) banal closed astatine $106.81 per share. One-month instrumentality of ICON Public Limited Company (NASDAQ:ICLR) was 9.43%, and its shares mislaid 27.21% implicit the past 52 weeks. ICON Public Limited Company (NASDAQ:ICLR) has a marketplace capitalization of astir $8.31 billion.

ClearBridge Mid Cap Strategy stated the pursuing regarding ICON Public Limited Company (NASDAQ:ICLR) successful its Q1 2026 capitalist letter:

"Health attraction was an country of weakness during the quarter. Declines were peculiarly prevalent successful declaration probe enactment ICON Public Limited Company (NASDAQ:ICLR) and integer wellness level Doximity, owed to capitalist concerns implicit the anticipation of AI disruption successful cause improvement and advertising. We exited our ICON presumption during the 4th but proceed to clasp a tiny presumption successful Doximity arsenic we judge that it is competitively good positioned and, contempt being caught up successful near-term disruption concerns, volition beryllium a semipermanent beneficiary of AI."

 Among Small-Cap Healthcare Stocks Hedge Funds is Buying

ICON Public Limited Company (ICLR): Among Small-Cap Healthcare Stocks Hedge Funds is Buying

ICON Public Limited Company (NASDAQ:ICLR) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 41 hedge money portfolios held ICON Public Limited Company (NASDAQ:ICLR) astatine the extremity of the 4th quarter, up from 43 successful the erstwhile quarter. While we admit the imaginable of ICON Public Limited Company (NASDAQ:ICLR) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article